- RON4.51bn
- RON6.28bn
- RON2.72bn
- 73
- 14
- 97
- 69
Annual cashflow statement for Med Life SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 78.6 | 135 | 49.6 | 4.3 | 39.1 |
| Depreciation | |||||
| Non-Cash Items | 43.3 | 38 | 43.5 | 92 | 111 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -96.1 | -59.7 | -60.9 | -110 | -119 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 129 | 227 | 185 | 184 | 286 |
| Capital Expenditures | -89.1 | -96.9 | -169 | -220 | -256 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -23.8 | -52.5 | -317 | -66.5 | -51.5 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -113 | -149 | -486 | -287 | -308 |
| Financing Cash Flow Items | -0.702 | -1.73 | -6.66 | -8.38 | -2.44 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.5 | -24.1 | 254 | 114 | 34.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 44.3 | 53.9 | -46.8 | 11.2 | 12.5 |